Vaxxinity (NASDAQ:VAXX) Upgraded by Zacks Investment Research to Hold

Vaxxinity (NASDAQ:VAXX – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Vaxxinity Inc. is a biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. Vaxxinity Inc. is based in DALLAS, Texas. “ Several […]

Related Keywords

United States ,Dallas ,Texas ,America , ,Vaxxinity Inc ,Jefferies Financial Group ,Geode Capital Management ,Goldman Sachs Group Inc ,Virtu Financial ,Zacks Investment Research ,Millennium Management ,Get Rating ,Financial Group ,Sachs Group ,Capital Management ,Adage Capital Partners ,Vaxxinity ,Nasdaq Vaxx ,Vaxx ,Medical ,Upgrade ,